StockData
AMREP Corp. logo

AMREP Corp. (AXR) stock analysis

AXRNYSELand Subdividers & Developers (No Cemeteries)Fiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026Score 10/301% above fair value
$21.12−0.32 (-1.49%)

Close on Nov 12, 2026Market cap $112.46MP/E 19.6Yield –

StockData Score

Prices as of Nov 12, 2026How the score works

Value2Growth0Performance3Health5Dividend0

Mixed10 of 30 checks passed

Amrep passes 10 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
2/6
Growth
0/6
Past performance
3/6
Financial health
5/6
Dividend
0/6

What stands out

  • No debt

    Amrep has no borrowings on its latest balance sheet.

  • Earnings grew over 5 years

    Net income grew 6.8% a year on average over the last five fiscal years.

  • Interest well covered

    No meaningful interest expense to cover.

  • Debt covered by cash flow

    There is no debt to cover.

What to watch

  • Margin of safety under 20%

    The price is 0.9% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $21.12 is above our fair value estimate of $20.92.

  • Return on equity under 15%

    Return on equity was 4.3% over the last twelve months and averaged 12.9% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 5.1%, below the 10% that usually covers the cost of capital.

Valuation2/6
  • P/E above its 5-year median

    Amrep's P/E of 19.6 is above its own 5-year median of 11.7.

  • P/E below the industry

    Amrep's P/E of 19.6 is below the Real Estate median of 23.4.

  • EV/EBITDA above its 5-year median

    Amrep's EV/EBITDA of 10.5 is above its 5-year median of 6.3.

  • P/B below the industry

    Amrep's price-to-book of 0.80 is below the Real Estate median of 0.97.

  • Trading above fair value

    The share price of $21.12 is above our fair value estimate of $20.92.

  • Margin of safety under 20%

    The price is 0.9% above fair value, so there is no margin of safety.

Growth0/6
  • Revenue growing under 10% a year

    Revenue grew 2.8% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -22.5% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -56.0% over the last twelve months, against a 5-year average of 6.8% a year.

  • Growing slower than the industry

    Revenue grew -15.3% over the last twelve months; the Real Estate median is 5.4%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin trend

    This company does not report gross profit.

Past performance3/6
  • Return on equity under 15%

    Return on equity was 4.3% over the last twelve months and averaged 12.9% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 5.1%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Amrep's return on equity of 4.3% is above the Real Estate median of 0.1%.

  • Earnings grew over 5 years

    Net income grew 6.8% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 14.3% over the last twelve months, against a 5-year average of 26.0%.

  • Net margin above the industry

    Amrep's net margin of 14.3% is above the Real Estate median of 0.8%.

Financial health5/6
  • No debt

    Amrep has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term liquidity

    The balance sheet is not split into current and non-current items.

  • Low bankruptcy risk

    The Altman Z-score is 16.29; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    Amrep has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Our estimate per share

$20.92

The share price is 1% above this estimate.

20%+ below
Near fair value
20%+ above
$21.12Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E18.7×11.7×23.4×$20.1840%
EV/EBITDA7.7×6.3×8.7×$17.9935%
P/B0.9×0.9×1.0×$24.5110%
Earnings power7.5% cost of equity––$27.3615%
Fair value$20.92100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 11.7
  • Real Estate median 23.4

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day
$134.57K
Value traded per 1% price move
$96.43K

Downside

Low risk

Typical loss in a bad month
13.5%
Volatility (annualized)
41%
Sharpe ratio, 1 year
-0.21
Beta to the S&P 500 (5Y)
0.46

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2012 to 2026

Gross margin

–

Operating margin

23.4%+0.9 pts over 5 years

Net margin

19.5%+1.0 pts over 5 years

See a number that looks wrong?